Evaluation of the impact of a training program on vitamin K antagonists (VKA) implemented by pharmacy students aiming at improving the knowledge of patients receiving vitamin K antagonists during their hospital clinical training course

• Published in: Annales pharmaceutiques françaises Vol. 72; no. 4; p. 287
• Main Authors: Conort, O, Siguret, V, Bourdon, O, Nazaraly, S, Brignone, M, Pons-Kerjean, N, Houze, S, Laribe Cage, S, Berthet, F, Golmard, J-L, Brion, F, Tilleul, P
• Format: Journal Article
• Language: French
• Published: France 01.07.2014
• Subjects: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants - adverse effects; Anticoagulants - therapeutic use; Female; Health Knowledge, Attitudes, Practice; Humans; Internship, Nonmedical; Male; Middle Aged; Patient Education as Topic - methods; Patients; Risk; Students, Pharmacy; Vitamin K - antagonists & inhibitors; Young Adult; Patient education; Étudiant en pharmacie; Accompagnement thérapeutique; Vitamin K antagonists; Antagonistes de la vitamine K; Pharmacy student
• ISSN: 0003-4509
• DOI: 10.1016/j.pharma.2014.02.004

We developed a training program for pharmacy students aiming at supporting patients receiving vitamin K antagonists (VKAs). The objective was to estimate how the program impacts VKA-treated patient knowledge acquisition and/or improvement on their anticoagulant treatment. Using dedicated tools, pharmacy students received education on VKA treatment. Once appointed to clinical wards of Assistance publique-Hôpitaux de Paris, they were in charge of evaluating patient's knowledge on VKA treatment before and after training. Evaluation was conducted using a face-to-face standardized interview (14-item questionnaire). A global score was calculated for each patient. An univariate and multivariate analysis was performed to identify potential variables influencing score result. One hundred and seventy VKA-treated patients were recruited in seven hospitals for evaluation of their knowledge on VKA treatment and on clinical at risk situations. Before intervention, patients obtained an average score of 12.3±3.2 (maximum: 18). Factors significantly associated with the score were possession of a VKA information booklet, VKA treatment duration, treatment initiation and age. Fifty-two patients with a low score were further trained by the pharmacy student. After intervention, their initial score was improved significantly, from 9.9±3.3 to 13.5±2.3 (P<0.0001). Increasing patient knowledge is a way to decrease the rate of adverse effects. This study demonstrates that patients with primary poor knowledge improved it significantly thanks to pharmacy students' intervention. This may contribute to lower the VKA-associated risk of adverse events and consequently to the improvement of patients quality of life and healthcare expenditures.